CMBM stock has a bearish outlook due to weak financial performance and industry challenges. The stock is currently rated as a "Sell" by Zacks, with a price target of $3, reflecting a significant downside from its current levels. Poor earnings results, declining revenues, and unfavorable defense market conditions contribute to this negative sentiment.